Use of fetal fibronectin in clinical practice

Obstetrical and Gynecological Survey

Volumn 52, Issue 4 SUPPL., 1997, Pages

  Ascarelli, Marian H ^a   Morrison, John C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FETOPROTEIN; FIBRONECTIN;

DIAGNOSTIC VALUE; FEMALE; HIGH RISK PATIENT; HUMAN; PATIENT MONITORING; PREDICTION; PREMATURE LABOR; PROTEIN DETERMINATION; REVIEW; SCREENING TEST;

EID: 0030890061     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199704000-00024     Document Type: Review

References (32)

1. McCormick M. Trends in rates of low birth weight in the United States. In: Berendes HW, Kessel S, Yaffe S, eds. Advances in the Prevention of Low Birth Weight. Washington, DC: National Center for Education in Maternal and Child Health, 1991, pp 3-11.
2. Meis PJ, Ernest JM, Moore ML et al. Regional program for prevention of premature birth in northwestern North Carolina. Am J Obstet Gynecol 1987;157:550-556.
3. Keirse MJNC, Grant A, King JF. Preterm labour. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective care in pregnancy and childbirth, vol. 1, Pregnancy. Oxford, England: Oxford University Press, 1989, pp 694-745.
4. Rust OA, Bofill JA, Arriola RM et al. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996;175:838-842.
5. Main DM, Richardson D, Gabbe SG et al. Prospective evaluation of a risk scoring system for predicting preterm delivery in black inner city women. Obstet Gynecol 1987;69:61-66.
6. Iams JD, Johnson FF, Hamer C. Uterine activity and symptoms as predictors of preterm labor. Obstet Gynecol 1990; 76(Suppl):42-46.
7. Katz M, Gill PJ, Newman RB. Detection of preterm labor by ambulatory monitoring of uterine activity: A preliminary report. Obstet Gynecol 1986;68:773-778.
8. Morrison JC, Martin JN, Martin RW et al. Prevention of preterm birth by ambulatory assessment of uterine activity: A randomized study. Am J Obstet Gynecol 1987;156:536-543.
9. Mou SM, Sunderji SG, Gall S et al. Multicenter randomized clinical trial of home uterine activity monitoring for detection of preterm labor. Am J Obstet Gynecol 1991;165:858-866.
10. Friedman SA, de Groot CJM, Taylor RN et al. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 1994;170:838-841.
11. Matsura H, Takio K, Titani K et al. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. J Biol Chem 1988;263:3314-3322.
12. Sibelle Y, Lwebuga-Mukasa JS, Polomski L et al. An in vitro model for polymorphonuclear-leukocyte-induced injury to an extracellular matrix: Relative contribution of oxidants and clastase to fibronectin release from amniotic membranes. Am Rev Respir Dis 1986;134:134-140.
13. Lockwood CJ, Senyei AE, Dische R et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-674.
14. Ahner R, Kiss H, Egarter C et al. Fetal fibronectin as a marker to predict the onset of term labor and delivery. Am J Obstet Gynecol 1995;172:134-137.
15. Feinberg FR, Kliman JH. Fetal fibronectin and preterm labor. N Engl J Med 1992;326:708-709.
16. Lockwood CJ, Moscarelli RD, Wein R et al. Low concentrations of vaginal fetal fibronectin as a predictor of deliveries occurring after 41 weeks. 1994;171:1-4.
17. Morrison JC, Allbert JR, McLaughlin BN et al. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993;168:538-542.
18. Peaceman AM, Andrews WW, Thorp JM et al, and the 031 Fetal Fibronectin Study Group. Abstract, presented at the 1996 Society of Perinatal Obstetricians Annual Meeting, Kona, Hawaii.
19. Iams JD, Casal D, McGregor JA et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141-145.
20. Bartnicki J, Casal D, Kreaden US et al. Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth weight infants. Am J Obstet Gynecol 1996;147:971-974.
21. Nageotte MP, Casal D, Senyei AE. Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 1994;170:20-25.
22. Morrison JC, Naef RW III, Botti JJ et al. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstet Gynecol 1996;87:649-655.
23. Katz M, Newman RB, Gill PJ. Assessment of uterine activity in ambulatory patients at high risk of preterm labor and delivery. Am J Obstet Gynecol 1986;154:44-47.
24. Bittar RE, Yamasaki AA, Sasaki S et al. Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996;175:178-181.
25. Lockwood CJ, Wein R, Lapinski R et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. 1993;169:798-804.
26. Goldenberg RL, Mercer BM, Meis PJ et al. The preterm prediction study: Fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996;87:643-648.
27. Hellemans P, Gerris J, Verdonk P. Fetal fibronectin detection for prediction of preterm birth in low-risk women. Br J Obstet Gynaecol 1995;102:207-212.
28. Greenhagen JB, Van Wagoner J, Dudley D et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol 1996;175:1054-1056.
29. Goldenberg R, Thom E, Moawad AH et al. The preterm prediction study: Fetal fibronectin, bacterial vaginosis, and peripartum infection. Obstet Gynecol 1996;87:656-660.
30. Burrus DR, Ernest JM, Veille JC. Fetal fibronectin, interleukin-6, and C-reactive protein are useful in establishing prognostic subcategories of idiopathic preterm labor. Am J Obstet Gynecol 1995;173:1258-1262.
31. Inglis SR, Jeremias J, Kuno K et al. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: Relation to outcome. Am J Obstet Gynecol 1994;171:5-10.
32. Garite TJ, Casal D, Garcia-Alonso A et al. Fetal fibronectin: A new tool for the prediction of successful induction of labor. Am J Obstet Gynecol 1996;175:1516-521.